Search for Clinical Trial Results
Leukemia, Hairy Cell - 25 Studies Found
Status | Study |
Completed |
Study Name: Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab Condition: Hairy Cell Leukemia (HCL) Date: 2014-05-21 Interventions: Drug: 2CdA +/- Rituximab Cladribine 0.14 mg/kg daily subcutaneous bolus injection Rituximab 375 mg/m |
Completed |
Study Name: A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia Condition: Hairy Cell Leukemia Date: 2007-12-21 Interventions: Biological: CAT 8015 (Moxetumomab Pasudotox) The dose level of the initial cohort will be 5 μg/kg s |
Completed |
Study Name: BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia Condition: Leukemia Date: 2003-12-10 Interventions: Drug: BL22 Dosing via IV on Days 1,3, and 5. |
Completed |
Study Name: Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia Condition: Leukemia Date: 2000-05-02 Interventions:
|
Completed |
Study Name: Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy Condition: Leukemia Date: 1999-11-01 Interventions: Biological: rituximab |
Completed |
Study Name: Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia Condition: Leukemia Date: 1999-11-01 Interventions:
|
Recruiting |
Study Name: 2CDA With Rituximab in Hairy Cell Leukemia Condition: Leukemia Date: 2006-12-14 Interventions:
|
Recruiting |
Study Name: Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease Condition:
|
Recruiting |
Study Name: Clinical Research in Hairy Cell Leukemia:Surveillance and Documentation of Clinical Outcomes Condition: Leukemia, Other Date: 2015-08-20 |
Completed |
Study Name: Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia Condition: Leukemia Date: 2001-08-10 Interventions: Biological: BL22 immunotoxin |